THERAPY: Low-dose aspirin to reduce the risk of pre-eclampsia?

    loading  Checking for direct PDF access through Ovid

Abstract

Numerous studies have evaluated the use of low-dose aspirin (LDA) to reduce rates of pre-eclampsia and adverse perinatal outcomes in women considered at risk of pre-eclampsia. A new study recommends that these women should receive LDA after 12 weeks of gestation to reduce the rates of pre-eclampsia, preterm birth and fetal growth restriction.

Related Topics

    loading  Loading Related Articles